Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx. - Bier,H.; Hoffmann,T.; Hauser,U.; Wink,M.; Öchler,M.; Kovar,A.; Müser,M.; Knecht,R. (Cancer Chemoth Pharmacol, 2001)